Cargando…

The remote effects of intravitreal anti-VEGF therapy

Objective: To study the effects of intravitreal anti-Vascular Endothelial Growth Factor (VEGF) therapy with Avastin for wet Age-Related Macular Degeneration (AMD) on Benign Prostatic Hyperplasia (BPH)-related symptoms. Methods: An exploratory trial was conducted from August 1, 2013 to February 1, 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balta, F, Merticariu, M, Taban, C, Neculau, G, Merticariu, A, Muresanu, D, Badescu, D, Jinga, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Carol Davila University Press 2016
Materias:	Case Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141400/ https://www.ncbi.nlm.nih.gov/pubmed/27928444

Ejemplares similares

Management of acute acquired comitant esotropia in children
por: Dragomir, Mihaela Sorina, et al.
Publicado: (2023)

Pediatric inflammatory multisystem syndrome induced Panuveitis associated with SARS-CoV- 2 infection: What the Ophthalmologists need to know
por: Merticariu, Corina Ioana, et al.
Publicado: (2022)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
por: Lima-Fontes, Mário, et al.
Publicado: (2022)

Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy
por: Bertelmann, Thomas, et al.
Publicado: (2017)

A new treatment approach – Eplerenone - in central serous chorioretinopathy - Case report
por: Cioboata, M, et al.
Publicado: (2016)

Collagen crosslinking in the management of microbial keratitis
por: Ramona, Barac Ileana, et al.
Publicado: (2016)

Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
por: Touzani, F., et al.
Publicado: (2019)

Issues with Intravitreal Administration of Anti-VEGF Drugs
por: Schargus, Marc, et al.
Publicado: (2020)

Inflammatory Complications of Intravitreal Anti-VEGF Injections
por: Cox, Jacob T., et al.
Publicado: (2021)

Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy
por: Kellner, Ulrich, et al.
Publicado: (2021)

Acute macular neuroretinopathy associated with intravitreal anti-VEGF injection: A case report
por: Radwan, Loubna M., et al.
Publicado: (2022)

Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
por: Agrawal, Shivi, et al.
Publicado: (2013)

Clinical impact of COVID-19 on patients with choroidal neovascularization on intravitreal anti-VEGF therapy
por: Agorogiannis, Eleftherios I., et al.
Publicado: (2021)

Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
por: Wahab, Charbel, et al.
Publicado: (2022)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
por: Lau, P. ET., et al.
Publicado: (2018)

Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma
por: Ucan Gunduz, Gamze, et al.
Publicado: (2019)

Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)
por: Reeves, Barnaby C, et al.
Publicado: (2011)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin, Ariana M, et al.
Publicado: (2017)

Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema
por: Lin, Dan, et al.
Publicado: (2022)

Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place of Intravitreal Anti-VEGF Therapy
por: Karti, Omer, et al.
Publicado: (2020)

Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
por: Elfalah, Mutasem, et al.
Publicado: (2021)

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
por: Barth, T., et al.
Publicado: (2019)

Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
por: Giocanti-Auregan, Audrey, et al.
Publicado: (2016)

Use of intravitreal anti-VEGF: Retinopathy of prematurity surgeons’ in Hamlet's dilemma?
por: Azad, Rajvardhan
Publicado: (2011)

Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2019)

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
por: Korobelnik, Jean-François, et al.
Publicado: (2020)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
por: Bunge, Casey C., et al.
Publicado: (2023)

Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
por: Koc, Hakan, et al.
Publicado: (2023)

Choroidal Neovascularization Associated with Punctate Inner Choroidopathy: Combination of Intravitreal Anti-VEGF and Systemic Immunosuppressive Therapy
por: Hohberger, Bettina, et al.
Publicado: (2015)

Impact of Intravitreal Anti-VEGF Therapy on Microperimetry of the Retinal Nonperfusion Areas of Patients with Proliferative Diabetic Retinopathy
por: Parravano, Mariacristina, et al.
Publicado: (2022)

The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model
por: Christoforidis, John, et al.
Publicado: (2012)

What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?
por: Avery, Robert L
Publicado: (2014)

Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice
por: Jo, Dong Hyun, et al.
Publicado: (2015)

Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
por: Pastor-Pascual, Francisco, et al.
Publicado: (2022)

Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept
por: Du, Liping, et al.
Publicado: (2015)

Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
por: Nguyen, Quan Dong, et al.
Publicado: (2023)

Risk of renal damage associated with intravitreal anti-VEGF therapy for diabetic macular edema in routine clinical practice
por: del Cura, Mar Prieto, et al.
Publicado: (2023)

Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
por: Gao, Lixiong, et al.
Publicado: (2019)

Short-term Efficacy of Intravitreal Dexamethasone Implant in Vitrectomized Eyes with Recalcitrant Diabetic Macular Edema and Prior Anti-VEGF Therapy
por: Shah, Ankoor R., et al.
Publicado: (2016)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ut3emh761ujjk582oq7o3iru1b